Transamerica Financial Advisors Trimmed Its Holding in Conocophillips (COP) by $619,677 as Share Value Rose; Merck & Co New Com (MRK) Holder Blackhill Capital Lifted Its Stake

June 14, 2018 - By Marie Mckinney

ConocoPhillips (NYSE:COP) Logo

Transamerica Financial Advisors Inc decreased its stake in Conocophillips (COP) by 92.1% based on its latest 2018Q1 regulatory filing with the SEC. Transamerica Financial Advisors Inc sold 10,503 shares as the company’s stock rose 15.69% while stock markets declined. The institutional investor held 901 shares of the integrated oil company at the end of 2018Q1, valued at $54,000, down from 11,404 at the end of the previous reported quarter. Transamerica Financial Advisors Inc who had been investing in Conocophillips for a number of months, seems to be less bullish one the $80.37 billion market cap company. The stock decreased 1.34% or $0.93 during the last trading session, reaching $68.69. About 1.99 million shares traded. ConocoPhillips (NYSE:COP) has risen 45.33% since June 14, 2017 and is uptrending. It has outperformed by 32.76% the S&P500. Some Historical COP News: 26/04/2018 – Conoco sues to enforce $2 bln award that Venezuela scorns; 02/04/2018 – CONOCOPHILLIPS HAD $250M IN 1Q DEALS TO SELL NON-CORE ASSETS; 04/05/2018 – ConocoPhillips Announces Quarterly Dividend; 04/05/2018 – CONOCOPHILLIPS COP.N SETS QUARTERLY DIVIDEND OF $0.285/SHR; 08/05/2018 – PDVSA halts Caribbean storage, shipping; diverts oil cargo -sources, data; 15/05/2018 – Conoco aiming to seize oil cargoes near Citgo’s Aruba terminal; 02/04/2018 – COP RECENTLY BOUGHT ~35K NET ACRES IN MONTNEY PLAY FOR ~$120M; 06/03/2018 – CERAWEEK – CONOCOPHILLIPS COP.N CEO SAYS ‘GENERALLY SPEAKING’ THE GLOBAL LNG MARKET IS OVERSUPPLIED RIGHT NOW; 28/03/2018 – CONOCOPHILLIPS – EARLY RESULTS OF TENDER OFFER CO TO PURCHASE UP TO $400 MLN IN AGGREGATE PRINCIPAL AMOUNT OF OUTSTANDING DEBT SECURITIES; 15/05/2018 – COP SEES FY 10+% OUTPUT GROWTH/DEBT-ADJ. SHR, 5+% MARGIN GROWTH

Blackhill Capital Inc increased its stake in Merck & Co Inc New Com (MRK) by 14.91% based on its latest 2018Q1 regulatory filing with the SEC. Blackhill Capital Inc bought 29,550 shares as the company’s stock rose 5.40% while stock markets declined. The institutional investor held 227,750 shares of the health care company at the end of 2018Q1, valued at $12.41 million, up from 198,200 at the end of the previous reported quarter. Blackhill Capital Inc who had been investing in Merck & Co Inc New Com for a number of months, seems to be bullish on the $165.06B market cap company. The stock decreased 1.22% or $0.7555 during the last trading session, reaching $61.3545. About 5.79 million shares traded. Merck & Co., Inc. (NYSE:MRK) has declined 9.15% since June 14, 2017 and is downtrending. It has underperformed by 21.72% the S&P500. Some Historical MRK News: 16/04/2018 – In CheckMate -141, Opdivo (nivolumab) Demonstrated Sustained Overall Survival (OS) Advantage over Standard of Care in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN); 16/04/2018 – BRISTOL-MYERS SQUIBB – IN PHASE 3 CHECKMATE -214 CLINICAL TRIAL, OPDIVO + YERVOY COMBINATION DEMONSTRATED A SIGNIFICANT INCREASE IN OVERALL SURVIVAL; 13/03/2018 – Merck Gets FDA Priority Review for Keytruda sBLA in Advanced Cervical Cancer; 09/04/2018 – KEYTRUDA® (PEMBROLIZUMAB) MONOTHERAPY MET PRIMARY ENDPOINT IN PHASE 3 KEYNOTE-042 STUDY, SIGNIFICANTLY IMPROVING OS AS FIRST-LINE THERAPY IN LOCALLY ADVANCED OR METASTATIC NSCLC PATIENTS EXPRESSING P…; 17/05/2018 – MERCK INDONESIA COMMENTS ON CONSUMER HEALTH SALE IN NEWSPAPER; 08/03/2018 – MERCK KGAA MRCG.DE SEES NEGATIVE FOREX IMPACT OF 4-6 PCT ON 2018 ADJ EBITDA; 16/04/2018 – Dynavax Reports Interim Data for SD-101 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Squamous Cell; 16/05/2018 – ASTRA’S DELIBERATIONS ON CRESTOR SAID TO BE AT EARLY STAGE; 08/03/2018 – MERCK KGAA MRCG.DE CEO RULES OUT TAKEOVERS LARGER THAN 500 MLN EUR AS LONG AS NET DEBT ABOVE 2 TIMES ADJ EBITDA, AIM IS TO BE BELOW 2 TIMES THIS YEAR; 17/04/2018 – Merck Announces First Phase Three Studies for PCV-15 (V114) Its Investigational Pneumococcal Disease Vaccine

Investors sentiment increased to 1 in Q1 2018. Its up 0.06, from 0.94 in 2017Q4. It is positive, as 72 investors sold MRK shares while 603 reduced holdings. 114 funds opened positions while 561 raised stakes. 1.91 billion shares or 1.08% less from 1.93 billion shares in 2017Q4 were reported. Franklin Res owns 49.10 million shares. Argent invested in 0.58% or 37,161 shares. 142,665 are held by Charter Trust. Cornerstone Investment Prtnrs Limited Company reported 17,248 shares stake. Tobam holds 0.05% or 23,672 shares in its portfolio. Alliancebernstein Limited Partnership holds 0.36% or 9.13M shares in its portfolio. Commerce Bank invested in 1.51 million shares or 1.09% of the stock. Consulate Incorporated has invested 0.16% in Merck & Co., Inc. (NYSE:MRK). Buckingham Asset Management Limited Liability owns 0.27% invested in Merck & Co., Inc. (NYSE:MRK) for 25,027 shares. Evermay Wealth Mgmt Ltd holds 0.36% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 19,310 shares. King Luther Management reported 1.56M shares stake. Century Cos has invested 0.53% in Merck & Co., Inc. (NYSE:MRK). Iowa Retail Bank, Iowa-based fund reported 48,326 shares. Central Secs invested 1.8% in Merck & Co., Inc. (NYSE:MRK). Bnp Paribas Asset Mngmt stated it has 0.46% in Merck & Co., Inc. (NYSE:MRK).

Among 24 analysts covering Merck & Co. Inc. (NYSE:MRK), 21 have Buy rating, 0 Sell and 3 Hold. Therefore 88% are positive. Merck & Co. Inc. had 90 analyst reports since August 13, 2015 according to SRatingsIntel. The stock of Merck & Co., Inc. (NYSE:MRK) has “Sell” rating given on Monday, July 17 by Jefferies. The firm has “Overweight” rating by JP Morgan given on Monday, September 21. The firm earned “Hold” rating on Thursday, November 16 by Jefferies. The rating was maintained by Jefferies on Friday, April 13 with “Hold”. Credit Suisse maintained it with “Outperform” rating and $65 target in Wednesday, February 14 report. The stock of Merck & Co., Inc. (NYSE:MRK) earned “Buy” rating by Bank of America on Tuesday, April 17. Bank of America downgraded the stock to “Neutral” rating in Wednesday, January 27 report. The stock of Merck & Co., Inc. (NYSE:MRK) earned “Hold” rating by Deutsche Bank on Monday, July 17. The stock of Merck & Co., Inc. (NYSE:MRK) earned “Buy” rating by Bernstein on Wednesday, November 15. Piper Jaffray maintained Merck & Co., Inc. (NYSE:MRK) on Friday, July 28 with “Buy” rating.

Blackhill Capital Inc, which manages about $660.31M and $536.34M US Long portfolio, decreased its stake in Zoetis Inc Cl A (NYSE:ZTS) by 5,400 shares to 342,766 shares, valued at $28.62 million in 2018Q1, according to the filing. It also reduced its holding in Disney Walt Co Disney Com (NYSE:DIS) by 4,200 shares in the quarter, leaving it with 230,200 shares, and cut its stake in Williams Sonoma Inc Com (NYSE:WSM).

More notable recent Merck & Co., Inc. (NYSE:MRK) news were published by: Streetinsider.com which released: “Merck (MRK) Announces FDA Approval of its KEYTRUDA for Treatment of Refractory or Relapsed PMBCL” on June 13, 2018, also Seekingalpha.com with their article: “Bristol Meyers Top NASH Contenders” published on June 12, 2018, 247Wallst.com published: “Major Pharmaceuticals Scare Off Short Sellers” on June 12, 2018. More interesting news about Merck & Co., Inc. (NYSE:MRK) were released by: Streetinsider.com and their article: “Merck (MRK) Says FDA Granted Priority Review to its sBLA for GARDASIL9 in Women and Men Ages 27 to 45 for …” published on June 13, 2018 as well as Streetinsider.com‘s news article titled: “Merck (MRK) Announces FDA Approval of its KEYTRUDA for Previously Treated Patients with Recurrent or Metastatic …” with publication date: June 12, 2018.

More notable recent ConocoPhillips (NYSE:COP) news were published by: Benzinga.com which released: “A Pair Trade In E&P: Bernstein Upgrades ConocoPhillips, Downgrades Concho” on June 08, 2018, also Seekingalpha.com with their article: “ConocoPhillips: Avoiding Traffic Jams” published on May 18, 2018, Fool.com published: “These 2 Oil Stocks Could Skyrocket in the Second Half of 2018” on June 13, 2018. More interesting news about ConocoPhillips (NYSE:COP) were released by: Fool.com and their article: “ConocoPhillips and Chevron Stock Win Analysts’ Favor: What You Need to Know” published on June 11, 2018 as well as Benzinga.com‘s news article titled: “BMO Offers 11 Reasons To Like ConocoPhillips” with publication date: June 11, 2018.

Among 28 analysts covering ConocoPhillips (NYSE:COP), 17 have Buy rating, 1 Sell and 10 Hold. Therefore 61% are positive. ConocoPhillips had 104 analyst reports since August 4, 2015 according to SRatingsIntel. Barclays Capital maintained ConocoPhillips (NYSE:COP) rating on Friday, February 2. Barclays Capital has “Overweight” rating and $72 target. Jefferies upgraded the shares of COP in report on Wednesday, September 7 to “Hold” rating. The firm earned “Market Perform” rating on Thursday, July 6 by Bernstein. As per Friday, March 31, the company rating was maintained by Cowen & Co. The stock of ConocoPhillips (NYSE:COP) has “Equal-Weight” rating given on Wednesday, October 18 by Morgan Stanley. The firm has “Outperform” rating by RBC Capital Markets given on Monday, October 31. The stock of ConocoPhillips (NYSE:COP) earned “Buy” rating by Vetr on Monday, August 24. As per Friday, January 19, the company rating was maintained by Jefferies. The stock of ConocoPhillips (NYSE:COP) has “Outperform” rating given on Tuesday, December 15 by Credit Agricole. On Friday, July 21 the stock rating was maintained by Citigroup with “Buy”.

Investors sentiment decreased to 0.67 in Q1 2018. Its down 0.05, from 0.72 in 2017Q4. It fall, as 51 investors sold COP shares while 555 reduced holdings. 101 funds opened positions while 302 raised stakes. 805.59 million shares or 0.00% less from 805.62 million shares in 2017Q4 were reported. Essex Mngmt Limited Liability has 70,525 shares for 0.55% of their portfolio. Waratah Capital Advisors Ltd stated it has 0.27% in ConocoPhillips (NYSE:COP). Roof Eidam And Maycock Adv holds 0.31% of its portfolio in ConocoPhillips (NYSE:COP) for 10,827 shares. Bkd Wealth Advsrs Lc reported 0.45% in ConocoPhillips (NYSE:COP). Sabal owns 5,773 shares for 0.03% of their portfolio. Tokio Marine Asset Communications reported 22,841 shares stake. Citigroup invested in 0.04% or 773,232 shares. Stock Yards State Bank And accumulated 60,122 shares. Penobscot Com owns 4,972 shares. Moreover, Massachusetts Communications Ma has 0% invested in ConocoPhillips (NYSE:COP). Eads & Heald Invest Counsel stated it has 0.88% in ConocoPhillips (NYSE:COP). Willis Counsel has invested 0.65% in ConocoPhillips (NYSE:COP). 35,146 were accumulated by Northside Cap Management Limited Liability Com. Westpac Banking reported 76,643 shares. Martingale Asset Mgmt LP holds 0.18% or 239,170 shares.

Analysts await ConocoPhillips (NYSE:COP) to report earnings on July, 26. They expect $0.92 EPS, up 557.14% or $0.78 from last year’s $0.14 per share. COP’s profit will be $1.08 billion for 18.67 P/E if the $0.92 EPS becomes a reality. After $0.96 actual EPS reported by ConocoPhillips for the previous quarter, Wall Street now forecasts -4.17% negative EPS growth.

Since March 29, 2018, it had 0 insider purchases, and 8 selling transactions for $20.96 million activity. 25,000 shares valued at $1.47M were sold by LUNDQUIST ANDREW D on Thursday, March 29. Another trade for 6,763 shares valued at $439,862 was sold by Schwarz Glenda Mae. Freeman Jody had sold 3,716 shares worth $243,586 on Monday, April 30.

Merck & Co., Inc. (NYSE:MRK) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Marie Mckinney

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: